
Bertil-16 Tablets by Qonexa Lifecare Pvt. Ltd. contain Betahistine 16 mg, a medicine prescribed for the management of vertigo and symptoms associated with Ménière's disease, an inner ear disorder affecting balance and hearing.
Betahistine is believed to act on histamine receptors and influence blood flow and pressure regulation in the inner ear. It may help reduce the frequency and severity of vertigo episodes in selected patients.
Bertil-16 Tablets are commonly prescribed for symptoms such as recurrent spinning sensations, dizziness, tinnitus and nausea associated with Ménière's disease. Treatment effectiveness may vary depending on the underlying condition.
The dosage and duration of treatment should be determined by a registered medical practitioner based on the patient's symptoms, medical history and response to treatment.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Qonexa Lifecare Pvt. Ltd. is a WHO-GMP certified pharmaceutical company based in Panchkula, Haryana, India. The company specializes in PCD (Propaganda Cum Distribution) pharma franchises and third-party/contract manufacturing services.
Key Details & Offerings
• Headquarters: Panchkula, Haryana
• Certifications: WHO-GMP compliant manufacturing and quality assurance standards
• Product Portfolio: Includes tablets, capsules, syrups, dry syrups, softgel capsules, injections, ointments, lotions, and an ayurvedic range.
• Business Model:
• District-wise monopoly rights for franchise partners
• Third-party and contract manufacturing for pharmaceutical and nutraceutical products
• Marketing and promotional support for distributors
• Contact Number: +91-8218719106
• Official Website: Qonexa Lifecare.